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Background: Obstructive sleep apnea has become recognized as one of the most common, 
under-diagnosed chronic diseases. Recently studies have shown increased numbers among the 
pediatric and adolescent population. OSA in children is associated with behavioral problems, 
poor school achievements, and in severe cases, pulmonary hypertension. OSA is often the 
Achilles heel of pediatric sedation and analgesic programs; during sedation, children with OSA 
have an increased vulnerability of their airway undergoing pharyngeal collapse and of having 
upper airway obstruction. Consequently, pediatric dentists who practice sedation dentistry should 
exercise extra precautions when treating patients with risk of sleep apnea. Currently there is no 
screening tool used in pediatric dentistry for diagnosing OSA during the pre-operative 
appointment or consultation for patients undergoing minimal and moderate oral conscious 
sedation. The purpose of this study was to develop and test a concise and easy-to-use 
questionnaire as a screening tool to aid in the diagnosis of OSA in pediatric patients. Materials 
and Methods: A retrospective chart review of 180 patients under the age of 18, who completed a 
polysomnogram at the VCU Center for Sleep Medicine between February 2011 and February 
2013. A validated adult questionnaire, STOPBANG, was modified using more typical pediatric 
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risk factors for OSA: presence of snoring (S), tonsillar hypertrophy (T1), tiredness; pESS>10 
(T2), observed  obstruction (O), neuroPsych-behavioral symptoms such as ADHD or daytime  
irritability (P), BMI percentile for age (B), age at diagnostic screening (A), presence of 
neuromuscular disorder (N), and presence of genetic/congenital disorder (G). A positive scoring 
from these variables was measured against the standard OSA measure, Apnea-Hypopnea Index. 
A multiple logistic regression analysis tested for relationships.  
Results: There was a statistically significant relationship P= .0007 for the S(T1)OPBANG scale, 
with a minimum of 4 variables needed to have a sensitivity of 57% and a specificity of 78%. 
There was also a statistically significant relationship P= .0040 for the S(T2)OPBANG, the 
cutoff>5 yielding sensitivity=36%, and specificity=90%. Only obstruction, BMI, and age 
showed a strong significant relationship to OSA. The presence of an obstruction was positively 
related to apnea (P = 0.0010). Most of the other components had an odds-ratio larger than one 
(indicating a nominally positive relationship). Conclusions: While both STOPBANG screening 
tools showed a statistically significant relationship, only obstruction, BMI, and age showed a 
predictive relationship to OSA. Consequently, consideration of other risk factors may be 
beneficial for future studies. 
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Introduction 
 
 
Sleep-disordered breathing encompasses a wide range of upper airway disorders from primary 
snoring (PS) to obstructive sleep apnea (OSA).  OSA results from impedance to air flow in the 
upper airway during sleep; these periodic obstructions of the upper airway interfere with normal 
respiratory gas exchange and subsequently interrupt sleep.1,2 OSA is measured by the Apnea-
Hypopnea index, which represents the total apneas and hypopneas per hour of sleep.3 Apnea 
denotes the cessation of airflow and is classified based on the pattern of respiratory effort. 
Hypopnea is a reduction in airflow.4 
 OSA has become recognized as one of the most common, under-diagnosed chronic 
diseases.5-7 People of all ages are affected with OSA, recently studies have shown increased 
numbers among the pediatric and adolescent population.8 The prevalence of obstructive sleep 
apnea (OSA) in children is estimated to be 1-3%,9 while primary snoring occurs in 3-12% of the 
pediatric population.10 A child with an AHI of greater than 5 events an hour emerges as having 
clinically significant OSA.11 Even brief obstructive apneas may be associated with significant 
hypoxemia due to children having a faster respiratory rate and lower functional residual capacity 
than adults.12 Mild cases of pediatric OSA are recognized and at times treated; however, 
measurable effects on development, cardiopulmonary or metabolic systems have been difficult to 
validate. OSA is associated with behavioral problems, poor school achievements, and in severe 
cases, pulmonary hypertension.2 Many studies have been conducted to identify adverse effects of 
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sleep disorders, yet few studies have examined how health care providers may identify and treat 
sleep disorders.13  
 Dentists who see their patients more frequently than their primary care doctors have a 
greater opportunity to observe signs and symptoms of OSA.8 However many potential sleep 
disorders in children are unrecognized and under-reported, and overall the condition is under-
diagnosed.14 Dentists who practice sedation dentistry should exercise extra precautions when 
treating patients with risk of sleep apnea. Minimal and moderate oral conscious sedation and 
general anesthesia are commonly used in pediatric dentistry; thus pediatric dentists have an acute 
responsibility to be able to identify patients who may have OSA.7 During sedation, children with 
OSA have an increased vulnerability of their airway undergoing pharyngeal collapse and of 
having upper airway obstruction.9  The risk of postoperative respiratory complications amongst 
the pediatric population ranges from 0 to 1.3%; however for children with OSA the rates have 
been reported to be 16-27%.15,16 The incidence of OSA in children is most elevated between ages 
2 to 6 years old. In this age range pharmacologic measures are most often used to complete 
diagnostic and therapeutic procedures.9  
 While polysomnography (PSG) remains the gold standard to diagnose OSA, there are 
many challenges due to the limited number of sleep laboratories and the high cost of using PSG 
on each child who snores and may be at risk.10 Polysomnography provides information 
pertaining to sleep patterns but fails to identify behavioral sleep disturbances.17 Available non-
PSG screening tests have poor sensitivity for milder OSA, and overall poor specificity.10 In 
extreme cases of OSA the clinical severity is easily determined with or without PSG, however it 
is the mild to moderate cases that are most difficult to diagnose. Moreover, there remains a 
challenge to differentiate PS from OSA in a “cost-effective, reliable, and accurate manner before 
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recommending invasive or intrusive therapies, such as surgery or continuous positive airway 
pressure”.10   
Sleep questionnaires that are completed by the parent and child are a crucial component of 
behavioral and physiological sleep assessment. Pediatric questionnaires are mostly retrospective 
in that the parents report on past sleep patterns and behaviors that are typical of their child. 
Questionnaires have been used alone or with other sleep assessment tools. Within the last 20 
years, the number of pediatric sleep questionnaires has greatly increased.17 Moreover, a review 
of sleep questionnaires from 2011 stated that there were “too many tools being used that have not 
undergone careful and methodical psychometric evaluation, and as such may be fraught with 
biased or invalid findings”.18 
 In 2008, Chung et al developed and validated a STOP questionnaire as a screening tool 
for OSA in patients 18 years and older. This questionnaire asks four yes or no questions: do you 
snore loudly?, do you feel tired during the daytime?, has anyone observed you stop breathing 
during your sleep?, and do you have high blood pressure? These questions along with body mass 
index, age, neck size, and gender (BANG) were found to have a sensitivity of 83.6, 92.9, and 
100% (for mild, moderate, and severe OSA, respectively).19	In 2006, the American Society of 
Anesthesiologists (ASA) Task Force on Perioperative Management of Patients with Obstructive 
Sleep Apnea recommended a checklist as a routine screening tool to utilize in surgical patients 
who may have OSA. The ASA checklist has 12 items for adults and 14 items for children, but 
was only validated by Chung for its use on adults.20  
 In 2011 Spruyt and Gozal published a review on Pediatric sleep questionnaires that 
examined 57 sleep measures that were used to screen children for sleep disorders including 
OSA.18 Only 2 questionnaires fulfilled all desirable criteria: The Sleep Disturbance Scale for 
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Children (SDSC) at a cut-off score of 39 provided a sensitivity of 0.89 and a specificity of 0.74 
21; and The Sleep Disorders Inventory for Students-Children (SDIS-C) showed a sensitivity of 
0.91 and a specificity of 0.62 for the category of Obstructive Sleep Apnea Syndrome.22 This 
review documented that few standardized screening tools exist thus far to determine risk for 
OSA in children.18 Pediatric Dentists and anesthesiologists alike would benefit from a standard 
screening tool, similar to the STOPBANG, to determine if OSA may exist in potential sedation 
and anesthesia pediatric patients.  
 Complications arise with diagnosing pediatric OSA because its presentation can differ 
from that of an adult. The exact pathophysiology of OSA in children has not been determined but 
it appears to result from both upper airway narrowing and upper airway hypotonia. Thus children 
with craniofacial abnormalities and neuromuscular disorders are at increased risk. The patency of 
the upper airway depends on pharyngeal dilating muscles. Children with neuromuscular diseases 
frequently present upper muscle airway weakness that can cause the airway to collapse. Upper 
airway narrowing is often a result of adenotonsillar hypertrophy. Despite past studies in which 
children with OSA typically have larger tonsils and adenoids than children who do not, the size 
of tonsils and adenoids does not predict the disease in individual persons. While excessive 
daytime sleepiness is a major complaint in adults with OSA, it is less common in children. This 
is most likely due to children maintaining their sleep architecture as they have a higher waking 
threshold than adults. Snoring has also been noted in both children and adults who have OSA. In 
prepubertal children, OSA occurs equally in both genders. However in adults, OSA occurs twice 
as often in males as in females. A large predisposing factor to OSA in adults is obesity. Obesity 
also appears to be a risk factor in children.12 Capdevila proposed the existence of two distinct 
types of OSA in children. Type I is associated with adenotonsillar hypertrophy in the absence of 
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obesity. Type II presents with “milder upper airway lymphadenoid hyperplasia” and obesity.23 It 
is fundamental to be able to identify both phenotypes that my present with signs of OSA.  
OSA is often the Achilles heel of pediatric sedation and analgesic programs,9 thus it is 
imperative that pediatricians and pediatric dentists be able to identify a child who may be at risk 
for OSA so that appropriate referrals for a definitive diagnosis can be made. Currently there is no 
screening tool used in pediatric dentistry for diagnosing OSA during the pre-operative 
appointment or consultation for patients undergoing minimal and moderate oral conscious 
sedation. 
 The purpose of the study was to develop a concise and easy-to-use questionnaire as a 
screening tool to aid in the diagnosis of OSA in pediatric patients.   
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Materials and Methods 
 
 
This project was approved under exempt status from the Virginia Commonwealth University 
Institutional Review Board (VCU IRB #: HM15027). 
This was a retrospective chart review of data previously collected as part of a routine 
screening exam for patients referred for a sleep study. The original data was collected at the 
VCU Center for Sleep Medicine for patients who presented from February 1st 2011 to February 
1st, 2013, with no previous sleep disorder diagnosis. Study data were collected and managed 
using REDCap electronic data capture tools hosted at Virginia Commonwealth University. 
REDCap (Research Electronic Data) is a secure, web-based application designed to support data 
capture for research studies.24 Prior to data collection, an excel file was created at the VCU 
Center for Sleep Medicine and included all patients under the age of 18 who had completed a 
polysomnography and thus had a definitive sleep disorder diagnosis. The excel file listed the 
following information for each patient: patient name, medical record number, age at the time of 
the study, and date of the polysomnogram. 
 In order to be included in the study patients must have met the following criteria: 
 Age < 18 
 Completed polysomnography with sleep disorder diagnosis 
 Sleep Questionnaire completed and scanned into chart 
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 Approximately 180 patients completed a polysomnography within the above time frame 
and were listed in the excel file. Using this listing of patients, data was gathered from 2 sources: 
Cerner, the Medical College of Virginia (MCV) electronic medical record, and the Sleep Center 
database. Paper charts for all patients prior to 2011 were currently inaccessible, so only 180 
charts were utilized in this study. A data collection sheet was fabricated to document each 
variable needed in this study (Appendix 1). No patient identifiers were collected or used during 
this study. The following variables were collected for this study: age of patient at time of PSG, 
gender, race, height, weight, body mass index, presence of snoring, presence of tonsillar 
hypertrophy, obstruction while sleeping, presence of neurobehavioral symptoms, daytime 
tiredness or irritability, presence of neuromuscular disorders, presence of genetic disorders, the 
patient’s Epworth scale score, and Apnea-Hypopnea index (AHI). The methods for determining 
each are given below. 
Date of PSG 
The date of the polysomnogram was recorded from the excel file after being verified on Cerner.  
Age 
Age at time of sleep disorder diagnosis was calculated using the electronic Cornell University 
age calculator (http://www-users.med.cornell.edu/~spon/picu/calc/agecalc.htm) in which the date 
of birth and date of polysomnography are entered to compute a patient’s age in years and 
months. Partial months were rounded down to whole numbers. As a risk factor, ages younger 
than 3 or older than 12 years were coded as “yes”. 
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Gender and race 
Race (when specified) was recorded as Caucasian, African American, Asian, Hispanic, or written 
in under “Other”. Gender was also recorded. Information on both of these variables was accessed 
under Patient Demographics in Cerner. 
Height, weight, body mass index 
If not provided in the chart, body mass index was calculated using the Centers for Disease 
Control and Prevention (CDC) BMI calculator for children and teens 
(http://apps.nccd.cdc.gov/dnpabmi/). The calculator computes BMI and the “BMI-for-age” 
percentile using the patient’s gender, age at time of measurement, height and weight. BMI-for-
age percentiles greater than 95% are coded as risk factor “Yes”. 
Presence of tonsillar hypertrophy 
This characteristic was coded as “Yes” when tonsillar hypertrophy was noted in the neurologist’s 
preoperative note. Many patients who were being screened for OSA had recently seen an 
otolaryngologist for tonsil evaluation. Preoperative notes were reviewed and tonsils recorded as a 
3+ or 4+ were marked “yes” for tonsillar hypertrophy. If a patient had a tonsillectomy, or if it 
was noted that the patient had tonsils 2+ or smaller, then tonsillar hypertrophy was marked as a 
“No”. “Unknown” was recorded when tonsils were not mentioned on any neurologist or 
otolaryngologist record during the time frame of the OSA screening.   
Presence of neurobehavioral symptoms 
Daytime neurobehavioral symptoms encompass attention deficit disorder with hyperactivity 
(ADHD), attention deficit disorder without mention of hyperactivity (ADD), and oppositional 
defiant disorder (ODD). These diagnoses were noted in the diagnosis section or at the top of the 
polysomnogram under patient’s history. For example, the top of a typical polysomnogram report 
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may read: “History: This 8 year-old female with a history of ADHD, Kabuki syndrome is being 
evaluated for obstructive sleep apnea contributing to daytime fatigue and hypersomnolence and 
loud snoring.” To verify these diagnoses the patient’s “Diagnoses and Problems” section was 
reviewed in Cerner. If no disorder was mentioned in these two sections or in the other sleep 
medicine documents, than the patient was recorded as not having any neurobehavioral 
symptoms.  
Presence of neuromuscular disorders 
This characteristic was coded as “Yes” when a neuromuscular disorder was recorded under the 
patient’s “Diagnosis” or if it was documented at the top of the polysomnogram report under 
patient’s history. “No” neuromuscular disorder was recorded when it was not mentioned in any 
of the above.  
Presence of genetic disorders 
This characteristic was coded as “Yes” when a genetic or congenital disorder was recorded under 
the patient’s “Diagnosis” or if it was found documented at the top of the polysomnogram report 
under patient’s history. “No” genetic or congenital disorder was recorded when it was not 
mentioned in any of the above.  
Sleep Study Questionnaire 
Prior to undergoing a sleep study, each patient along with their parent would complete a sleep 
questionnaire called “The VCU Center for Sleep Medicine: New Patient Questionnaire” 
(Appendix 2). This five page document consisting of the Sleep-50 Questionnaire, gave each 
patient the opportunity to complete the Epworth Scale, give a detailed medical history, and 
respond to specific statements about a patient’s sleep hygiene25. Patients were asked to rate to 
what extent a statement was applicable to them by circling 1, 2, 3, or 4. The number one 
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corresponded to “Not at all”, 2 indicated “somewhat”, 3 “rather much” and 4 “very much”. The 
prefabricated data sheet asked data collectors to determine whether the patient believed they 
snored, had sleep obstruction, or was excessively tired or irritable during the day. Data collectors 
recorded “Yes”, “No” or “unknown” to these variables. If the patient had circled 3 or 4 
corresponding to a statement than that was considered a positive (yes) for whether the patient 
had the symptom specific to that statement. A 1 or 2 indicated a negative response for the 
symptom. The following variables below utilized the Sleep Study Questionnaire. 
Presence of snoring 
This characteristic was recorded solely based on the patient reporting symptoms and not on 
whether the patient snored during the polysomnography. Snoring was coded as “Yes” when 
snoring was noted on patient’s referral form, noted in the neurologist’s preoperative notes, or 
when the parent and patient recorded a “3” or “4” when responding to the question “I am told 
that I snore”. In the sleep questionnaire “1” corresponds to Not at all, a “2” simulates 
“somewhat”, a “3” denotes rather much while “4” means very much that the patient has certain 
symptoms. “No” was recorded when a patient selected 1 or 2 when responding to the question “I 
am told that I snore”, or when the neurologist had noted that the patient did not snore. 
“Unknown” was recorded when snoring was not mentioned in the doctor’s preoperative note, the 
referral form, or when the sleep questionnaire was not completed. 
Obstruction while sleeping 
This characteristic was recorded based on the patient’s symptoms. Sleep obstruction was coded 
as “Yes” when sleep obstruction was noted on the patient’s referral form, noted in the 
neurologist’s preoperative notes, or when the parent and patient recorded a “3” or “4” when 
responding to the questions: “I am told that I hold my breath when sleeping” and “I am told that I 
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wake up gasping for air”. “No” was recorded when a patient selected 1 or 2 when responding to 
the same questions, or when the neurologist had noted no past history of obstruction. Unknown 
was recorded when sleep obstruction was not mentioned in the doctor’s preoperative note, the 
referral form, or when the sleep questionnaire was not completed. 
Daytime tiredness or irritability 
This characteristic was coded as “Yes” when the patient recorded a “3” or “4” when responding 
to the majority of the following questions: “I feel tired at getting up”, “I feel sleepy during the 
day and struggle to remain alert”, “I would like to have more energy during the day”, “I am told 
that I am easily irritated”, or “I have difficulty in concentrating at work or school”. No was 
recorded when the patient had marked a “1” or “2” to a majority of these questions. Unknown 
was recorded if the sleep questionnaire had not been completed. 
Apnea-Hypopnea index (AHI) 
As previously mentioned, OSA is primarily diagnosed by a patient’s apnea-hypopnea index 
(AHI). The AHI represents the average number of apneas and hypopneas per hour of sleep10 and 
was obtained from each polysomnogram. In children, more than one obstructive apnea event of 
any length per hour of sleep is considered abnormal.26,27 Based on these recommendations, in 
this study mild AHI was defined as >1.5, moderate >5 and severe >15. For the purposes of 
analysis, AHI was categorized two ways. One categorization characterized apnea as: none (AHI 
≤ 1.5), mild (AHI > 1.5), moderate (AHI > 5), or severe (AHI > 15). The primary categorization 
was a binary outcome: apnea negative (AHI ≤ 5) or apnea positive (AHI > 5). 
S(T1)OPBANG 
There were two scales evaluated, differing only in the “T” variable. S(T1)OPBANG was the sum 
of the presence of snoring (S), tonsillar hypertrophy (T1), observed  obstruction (O), neuro-
 12 
psych-behavioral symptoms such as ADHD or daytime  irritability (P), BMI percentile for age 
(B), age at diagnostic screening (A), presence of neuromuscular disorder (N), and presence of 
genetic/congenital disorder (G). Yes values were scored as 1 and all other values (No and 
unknown) were scored as zero in the calculation of the sum. 
S(T2)OPBANG 
The S(T2)OPBANG score was calculated as above but tiredness evaluated through the Epworth 
scale; pESS>10. (T2) replaced tonsillar hypertrophy. 
Purpose 
The primary aims of the study were to test two scales for the identification of sleep apnea in 
children. The secondary aims were to test each of the components of the sleep apnea scale. 
Data analysis 
All the information from the data sheets was entered into a REDCap database for analysis. A 
second party for input errors checked all information entered. All analyses were performed using 
SAS software by the project biostatistician, Dr. Best. All of the patients were described 
according to the STARD standard for reporting diagnostic accuracy.28 This includes complete 
reporting of patients excluded from study. The statistical methods included screening of each 
diagnostics characteristic (using chi-square analysis) and a multiple logistic regression analysis 
of the OSA diagnosis to determine which diagnostics characteristics are associated with the 
diagnosis. Final reporting included odds-ratios and 95% confidence intervals on all estimates.  
Using the projected 250 charts that were initially thought to be available, and estimating the 
prevalence OSA of at least 25% and odds-ratios of at least 2, the study had approximately 80% 
power (at alpha=0.5). 
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Results 
 
 
There are three major sections included in the Results: The first section is a description of the 
results of the process from the identification of potential subjects to the building of the final 
analysis dataset, and a description of the subjects analyzed. The second section includes the 
testing of the primary aims. The third section denotes the exploration of each of the components 
and the proposal of a revised scale. 
Data gathering and Description of subjects 
The sleep study questionnaire was completed on paper and scanned into the patient’s chart in 
Cerner. Occasionally sleep study questionnaires were not scanned into Cerner or parents and 
patients did not complete the sleep study questionnaire in its entirety. If the variables were 
unable to be collected that particular patient was excluded from the study. Often this information 
was gleaned from a direct referral form previously completed by a primary care physician or a 
specialist such as an Otolaryngologist. The referring doctor would complete the Patient History 
section, in which they could check such parameters as excessive daytime sleepiness, loud 
snoring, neuromuscular disease, obesity, observed apneas, wakes with choking/gasping. 
Referring doctors could also write in other diagnoses that were not listed. This direct referral 
form was used in lieu of a sleep questionnaire if all parameters were answered and if it was 
evident the patient was nonverbal and could not complete the sleep questionnaire. Otherwise the 
patient was excluded due to lack of information. A total of 153 subjects with usable data were 
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analyzed. 54% were male and the predominant race groups were whites (45%) and blacks (43%, 
See Table 1). Neither gender (P = 0.4455) nor race (P = 0.1368) appeared related to the AHI 
scores. Subjects ranged in age from 38 months to 17.5 years (mean = 10.6, SD = 4.1). Subjects 
ranged in height from less than a meter (3 feet) to 1.88M tall (6 foot 2 inches). One height was 
not available for a subject. Subjects ranged in weight from 12.7kg (28 pounds) to 189kg (416 
pounds). Height was roughly normally distributed, but weight was skewed, as is indicated by the 
fact that the median weight (42kg) was considerably lower than the mean weight (50kg). BMI 
was calculated from height and weight and averaged 23.32kg/m2 (SD = 8.9). Since the amount of 
body fat changes with age and differs between boys and girls, the BMI-for-age percentiles are 
used for comparisons. BMI-for-age is strongly skewed with a large number of percentiles at 95% 
or above. There were 60 subjects (39%) who were described as obese since they were above the 
95th percentile for age and gender. Another 27 subjects (18%) were overweight (between the 85th 
and 95th percentile). Only 54 subjects (36%) had what is considered a healthy weight (between 
the 5th and 85th percentile); 11 subjects were underweight (7%). 
Scales 
There were two scales tested in this study and the components for each are summarized in Table 
2. Over 59% of all subjects had a positive indication in the medical record for snoring (n = 91) 
but 11 subjects lacked any reference in the record regarding snoring (7%). For the purposes of 
the scale score, a “yes” was counted as positive and both “no” and “unknown” were not counted 
as positive (and so they are effectively counted as negative). Thus the prevalence of each of these 
components ranged from a high of 59% (snoring) to a low of 14% for both neuromuscular 
disorders and for genetic/congenital disorders.  
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Note that for the purposes of the scales, daytime neurobehavioral symptoms and 
excessive tiredness during daytime were combined such that if either was a “yes,” the 
combination was scored as a positive. There were 13 “yes” for both, 13 “yes” on daytime 
neurobehavioral symptoms only, and 66 “yes” on excessive tiredness. And so there were 92 
yeses on this combined indication (60%), 60 no (39%), and only 1 unknown (1%). 
The primary outcome variable was observed apneas and hypopneas, as indicated by AHI. 
The raw AHI values ranged from 0 to 85.7, with a median value of 0.8. The strongly skewed 
values yielded a mean of 4.08 (SD = 9.53). Table 3 indicates that 82% (96=none, and 29=mild) 
were considered negative for apnea and therefore that 18% (16 moderate and 12 severe) were 
considered positive. 
For the S(T1)OPBANG scale (snoring, tonsillar hypertrophy, sleep obstruction, daytime 
neurobehavioral symptoms/tiredness, BMI, age, neuromuscular and genetic), the scores ranged 
from 0 to 6 (Mean = 2.76, SD = 1.34) and for the S(T2)OPBANG scale (snoring, Epworth, sleep 
obstruction, daytime neurobehavioral symptoms/tiredness, BMI, age, neuromuscular, and 
genetic), the scores ranged from 0 to 6 (Mean = 2.84, SD = 1.42, see Table 4). Since they share 
components, it is not surprising that the two scores are strongly correlated (r = 0.90, P < .0001). 
Logistic regression was used to test for a relationship between the S(T1)OPBANG scale 
and apnea. There was a statistically significant relationship (likelihood ratio chi-square = 11.5, P 
= 0.0007). Table 5 shows the relationship between each scale value and the sensitivity and 
specificity. For instance, if S(T1)OPBANG≥6 is used as a cutoff, then 2 subjects are predicted to 
be positive. Of the 28 actual positives one has a cutoff 6 or greater and so the sensitivity is 4% 
(1/28). Of the 125 actual negatives, all but one has a cutoff below 6 and so the specificity is 99% 
(124/125). As the cutoff decreases, sensitivity must go up and specificity must go down. If the 
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risk of false positives and false negatives were equal, then the cutoff yielding the largest 
sensitivity + specificity would be the optimal cutoff. In the case of S(T1)OPBANG, this cutoff is 
4 (sensitivity=57%, specificity=78%). 
For the S(T2)OPBANG scale there was also a statistically significant relationship 
(likelihood ratio chi-square = 8.27, P = 0.0040). Table 6 shows the relationship between the 
sensitivity and specificity and each scale value. In the case of S(T2)OPBANG, the cutoff 
yielding the largest sensitivity + specificity is 5 (sensitivity =36%, specificity = 90%). 
One way to determine which of the two scales might be preferred is to use both as 
predictors in a multiple logistic regression. This indicates that when S(T1)OPBANG is used as a 
predictor, S(T2)OPBANG provides no additional predictive value (P = 0.70). Conversely, if 
S(T2)OPBANG is used as a predictor, then S(T1)OPBANG provides some additional predictive 
value (P = 0.0644). 
Analysis of the components 
Each of the individual components was first screened using a chi-square test (Table 7). The 
results indicate that the only statistically significant risk factor was sleep obstruction (P=0.001). 
However all components had a relative risk value greater than 1 except for neuropsych-
behavioral symptoms/tiredness (RR=0.77). A multiple logistic regression analysis was used to 
test the significance of each of the components of the scales and shows the results for the 
components of S(T1)OPBANG (Table 8). Although the test that all eight components provided 
predictive value was significant (P = 0.0024), only one component was individually significant. 
The presence of an obstruction was positively related to apnea (P = 0.0010). Most of the other 
components had an odds-ratio larger than one (indicating a nominally positive relationship). 
However, two components—snoring and neurobehavioral symptoms/daytime tiredness had odds 
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ratios below one, which indicates that the presence of the component is negatively related to 
apnea. Similar results were found for the components of S(T2)OPBANG (Table 9). That is, 
although 23% of those who snore were OSA positive and 11% of those who did not snore 
(RR=2.04), after all of the other risk factors were taken into account, snoring was not a 
significant predictor of OSA (OR=0.74, P>0.6). Similarly 26% of children with tonsillar 
hypertrophy had OSA and16% of those who did not (RR=1.57). But tonsillar hypertrophy was 
not significant after others were accounted for (OR=1.96, P>0.2). There was no evidence that an 
Epworth score greater than 10 was related to OSA since those who were above the cutoff had 
19% OSA, as compared to 18% of those below the cutoff. On the other hand of those with a 
sleep obstruction 34% were positive for OSA and only 9% of those without a sleep obstruction 
were positive to OSA (RR=3.98). This remained a significant predictor of OSA (OR=7.56, 
P=0.0010). Being positive for either neurobehavioral daytime symptoms or excessive daytime 
tiredness/irritability was actually nominally protective against OSA since there were fewer OSA 
case in those who were positive than in those who were negative (16% vs 215). Obese children 
were OSA positive 25% of the time and non-obese children 14% (RR=1.79) but the adjusted 
analysis did not indicate that it was a significant predictor (OR=1.90, P>0.2). Those in the age 
risk categories were OSA positive 23% of the time whereas those who were in the middle ages 
were positive 16% of the time (RR=1.42) but age was not statistically significant in the adjusted 
analysis (OR=2.42, P=0.1004). This result is suggestive, however. Those with neuromuscular 
diagnoses were as likely to be OSA positive than those without these diagnoses (19% vs 18) and 
the adjusted analysis also did not support a significant relationship (OR=3.06, P=0.1482). Again, 
this is a suggestive result. And those with genetic/congenital defects were more likely to be OSA 
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positive than those without these conditions (24% vs 17%, RR=1.37). Moreover, the adjusted 
analysis advocate some potential for a relationship (OR=3.71, P=0.0648). 
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Discussion 
 
 
In this retrospective chart review, specific variables were compared with AHI scores in order to 
develop a screening tool with a high sensitivity and also a high specificity for pediatric 
obstructive sleep apnea. Less than half of children with OSA symptoms actually have the 
syndrome.29 As a result screening for OSA is very complicated and causes many children to go 
undiagnosed. Presently, pediatric OSA is under diagnosed and as a result undertreated because of 
the high cost to test for OSA and the limited number of pediatric sleep laboratories. 
Consequently screening for OSA has become essential.30 A recently published systematic review 
and meta-analysis by Canto et al (2014) explores the diagnostic value of alternative methods 
such as clinical history and physical examination to identify pediatric OSA, and also validates 
the role dentists play in screening patients.31 In the following discussion, the findings of the 
current study will be compared to the results of Canto’s systematic review where applicable. The 
results of the current study found a clinically significant correlation between each proposed scale 
and AHI, however only one individual component was strongly related to AHI. Suggesting that 
certain variables that present together in a single individual may predispose that person to OSA, 
more so than individual parameters.  Below each variable evaluated in this study is dissected 
along with present findings and suggestions for a revised screening tool based on these results.  
 In a review on sleep disordered breathing in children, Padmanabhan et al. ascertained that 
snoring, apnea, and difficulty in breathing were the three main symptoms of OSA in children and 
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infants. Snoring occurs in almost all children with a sleep disorder; often it is the catalyst for 
parents to believe there is a problem and to pursue a medical consult.32 Parents who hear their 
children snore perceive them struggling to breathe and often are anxious about their nighttime 
breathing habits.10 Furthermore, snoring remains the most common complaint in sleep-
disordered breathing for children under five years old.26 Interestingly enough, only a fraction of 
children who snore have OSA,32,33 and the presence of snoring alone cannot accurately predict 
OSA.10 Habitual snoring is a hallmark of sleep-disordered breathing and denotes loud snoring at 
least three nights per week.34 A great number of children who habitually snore have primary 
snoring, which is habitual snoring without changes in ventilation or oxygenation.30 The 
correlation between snoring and AHI in our study overall had a very weak relationship both 
individually (P=0.0642) and once all values were adjusted for every component (P=0.6767). 
These results reflect our sample of patients as all subjects presented to the sleep center citing 
sleep difficulty. Our study suggests a correlation that is not necessarily predictive, reinforcing the 
idea that the presence of snoring does not automatically ascertain that the child has OSA.10 
Young et al determined 10-14% of children snore every night or every other night, and found a 
prevalence of OSA in 10 to 20% of habitual snorers.35 Our results are similar- 21 out of 91 
subjects who reported snoring exhibited moderate or severe OSA. Canto et al evaluated three 
snoring characteristics and reported the sensitivity and specificity of each: snoring disturbs others 
(sensitivity = 68% and specificity = 58%), snoring every night (sensitivity = 91% and specificity 
= 75%) and snoring extremely loudly (sensitivity = 52% and specificity = 78%). Snoring every 
night had the highest sensitivity with fair specificity.31 Unfortunately snoring was not quantified 
in this retrospective chart review, and so parents may have reported their child snored even when 
it was infrequent. Moreover, our study was limited in that data relied on reporting of parents who 
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likely have varying subjective standards for what they consider “snoring” and also vary in their 
opportunity to observe the behavior. Snoring alone is not a sensitive indicator of OSA, but 
because it is a prevalent symptom of OSA it remains a useful variable in our screening tool.  
 As mentioned above, sleep obstruction is another common symptom of children with 
OSA and represented the O in our study.  Obstructive apnea occurs when there is respiratory 
effort and lack of airflow.36 In adults obstructive events need to be at least 10 seconds long in 
order to be scored. However, in children the obstructive events need to occur over 2 breaths or 
more.4 A different standard is necessary as children have a faster respiratory rate and lower 
functional residual capacity. Moreover, shorter respiratory events in children have more 
physiological consequences.10 Our results exemplified a strong ordinal relationship with AHI and 
obstruction (P=0.0010), with a sensitivity of 71% and a specificity of 69%. It is surmised that 
there is a strong correlation for two reasons, first the obstruction that parents report most likely 
represent the apnea and hypopnea events significant for OSA, and second, choking and gasping 
during sleep is a very distinct sound that may be definitively distinguished from that of snoring. 
Consequently while other symptoms reported by parents may not always be accurate, it is 
difficult to misinterpret pauses in breathing exemplified by “choking and gasping sounds”. In 
Canto et al, evaluation of whether pauses in breathing were diagnostic were not as definitive. 
Observable apnea only showed a sensitivity = 36% with a strong specificity = 95%. Observed 
obstructive apneas had almost equal sensitivity and specificity, with 61 and 65%, respectively.31 
In this study obstruction represents the variable with the strongest correlation to AHI and thus 
remains in our revised screening tool. 
 For the T component of our modified STOPBANG we utilized two different variables- 
tonsillar hypertrophy and tiredness reflected through the value of the Epworth scale. Neither of 
 22 
these variables showed a significant correlation with AHI in this study (P=0.2449 and P=0.4831, 
respectively). Presently the most common identified risk factor in childhood OSA is 
adenotonsillar hypertrophy.2,37,38 Lingual and pharyngeal tonsils can be visualized intraorally 
whereas adenoids cannot. Tonsillar size can range from Type 0 where the tonsils are absent to 
Type IV where the right and left tonsillar tissue approaches the midline. Based on Scammon’s 
growth curve, lymphatic tissue begins to shrink after the age of six but the presence of large 
tonsillar and adenoid tissue may negate this normal reduction and obstruction may persist.8 The 
primary treatment for OSA in children is adenotonsillectomy.2,37,38 Removal of the adenoids and 
tonsils relieves crowding in the airway and permits air to flow more freely through the nasal and 
oral passages.2 In The Childhood Adenotonsillectomy Trial (CHAT) by Marcus et al., watchful 
waiting was compared to the outcomes of removing the tonsils in school-age children. This study 
found that patient’s symptoms overall improved as well as quality of life and polysomnography 
findings. However surgical treatment did not improve attention or function evaluated through 
neuropsychological testing.37 Like snoring, the presence of large tonsils does not automatically 
give the patient OSA. Several studies have reported that no relationship exists between the size 
of the tonsil and adenoids and the presence of OSA.10,39,40 Canto et al systematic review found 
overall weak results concerning tonsils: with sensitivity = 69% and specificity = 53% for 
tonsillar hypertrophy and sensitivity = 81% and specificity = 58% for Grade 3 tonsil size.31 
There was not a significant correlation in our study to size of tonsils and AHI (P=0.2449). 
However this study was limited in that tonsillar hypertrophy was not routinely recorded. If the 
patient did not have a direct referral there would be an initial visit where size of tonsils was often 
noted. Frequently patients would also seek out an otolaryngologist around the same time frame 
where the size of the tonsils was noted. Tonsillar size was gleaned from these two documents. A 
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little less than half (72 out of 153) of the subjects’ tonsil size was unable to be reported. These 
unknowns were recorded as “no” in the data analysis. These limitations likely cause the data in 
this study to underreport tonsillar hypertrophy. Despite these results and the lack of literature 
ascertaining tonsillar hypertrophy to predict OSA, it continues to a major cause of OSA2 and 
consequently will remain in the revised screening tool.  
 The Epworth Sleepiness Scale (ESS) measures a person’s general level of daytime 
sleepiness. It contains 8 questions that explore a person’s propensity to fall asleep during the day. 
Scores range from 0 to 24. In adults, a score of greater than 10 suggests heightened daytime 
sleepiness. In a study by Melendres et al., researchers modified the ESS to be more applicable to 
children. The suggestion of alcohol was deleted in question 7 and driving a car in question 8 was 
changed to being a passenger in a car. Melendres’ study found that the ESS score of patients with 
OSA was not statistically different from those with primary snoring. Their results did not 
illustrate a difference between the ESS score of patients with mild, moderate, and severe OSA.41 
These results are similar to those in the present study where the ESS had no relationship to AHI 
(P = 0.4831). Parents and patients were asked to complete a typical 8 question ESS that was not 
modified for children (Appendix 3). Scores above 10 signified excessive sleepiness. These 
results, similar to the Melendres study, suggest that ESS holds little value in predicting OSAS 
and will be omitted in the revised screening scale.  
 The P in our modified STOPBANG screening tool represents neuropsych-behavioral 
symptoms in which excessive tiredness and irritability during the daytime was combined with 
daytime neurobehavioral symptoms. Positive scores of neurobehavioral symptoms required a 
diagnosis from a medical professional of either attention deficit disorder with hyperactivity 
(ADHD), attention deficit disorder without mention of hyperactivity (ADD) or oppositional 
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defiant disorder (ODD).  This variable was analyzed because daytime hyperactivity and 
inattention have been shown to be associated with restless sleep. Moreover, improved sleep 
patterns have led to positive changes in behavior.23,42,43 Sleep fragmentation, which is prevalent 
in pediatric OSA, may result in impaired daytime functioning.23,44,45 Relationships between OSA, 
hyperactivity, and inattentive behavior have been documented.23,46-51 Yet excessive tiredness, 
irritability, and hyperactivity are widely prevalent in children without OSA.23,41,52-56 Unlike 
adults, children do not have the degree of daytime tiredness with sleep disordered breathing 
because their nighttime obstructive spells are more transitory and the periods of arousal are less 
discernable.32 The occurrence of excessive daytime sleepiness in children with OSA is vague as 
it depends on the perception of the parents or caretakers. Young children most likely will not 
report tiredness.23 In this retrospective chart review, parents completed the sleep questionnaire 
for the majority of subjects under the age of 12, their answers seemingly subjective and naturally 
influenced by their own thoughts, feelings, and attitudes on tiredness and their child’s irritability. 
The results of this study indicated no relationship to AHI score and the reporting of excessive 
tiredness/irritability (P=0.3191). This study found that higher AHI scores were apparent in those 
with neurobehavioral daytime symptoms however it was not significant. Literature on 
neurobehavioral symptoms exemplifies a wide range of results. In a study by O’Brien et al., 26% 
of children with mild symptoms of ADHD were shown to have OSA via a polysomnograph.14,57 
A more recent study found that in children 6 to 14 years old with ADHD, OSA was not a 
common underlying disorder or etiologic factor.14,58 Yet there is evidence to show persistent 
sleep disturbance can affect cognition, mood, behavior, and family function.14,59 As mentioned 
previously, the CHAT study conducted by Marcus et al. ascertained that surgical treatment for 
OSA in school-age children, while improving symptoms and quality of life, did not improve 
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attention or executive function.37 Canto’s review showed attention deficit/hyperactivity disorder 
to have a sensitivity = 52% and a specificity = 67%, not an overall strong correlation.31 Based on 
the lack of evidence that psycho-behavioral symptoms and reports of tiredness/irritability have 
significant predictive value, this variable will be omitted in the revised scale.	
 The B in this retrospective chart review denotes body mass index (BMI) percentile for a 
given age. Due to varying changes in height and weight during a child’s growth and 
development, BMI percentiles specific for age and sex are the best way to depict childhood 
weight status. BMI > 95% indicates an obese child. BMI > 85-94% represents children who are 
overweight. Underweight children are in the BMI < 5% category.60 It was proposed that BMI 
percentiles above 95% would place a patient at risk for OSA. Obesity has been found to 
predispose patients to OSA due to the mass loading of upper airway and respiratory muscles, in 
addition to impairment of ventilation. OSA in obese children ranges from 13 to 36%, based on 
the severity of obesity.61,62 A review of the scatterplot (Figure 4) indicates that in this study not 
only are patients above the 85th percentile at risk for OSA, but also patients below the 10th 
percentile for BMI. These differences in BMI appear to account for the two types of pediatric 
OSA: Type I: non obese with adenotonsillar hypertrophy and Type II: obese with mild upper 
airway lymphadenoid hyperplasia23 that were proposed earlier. With obesity on the rise, it is easy 
to forget that traditionally, OSA children were non-obese.63,64 Case series have suggested that 
growth (especially weight gain) accelerates after surgery for OSA, proposing that OSA may 
inhibit growth.65-68 These results agree with the findings in this study, that not only are 
overweight and obese children predisposed to OSA, but underweight children may also indicate 
OSA. Furthermore, BMI percentiles >85% and <10% appear to be a risk factor for OSA and 
these parameters will reside in the revised screening tool.  
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 In our study age presents the A in STOPBANG and was defined as a risk factor for 
patients younger than 3 or older than thirteen. Evidence of systematic variability with age in 
pediatric OSA is lacking.69 Pediatric OSA can occur at any age from birth to adolescence, 
however it is most common in the preschool age according to the International Classification of 
Sleep Disorders Diagnostic and Coding Manual.12 It has been reported that the peak incidence of 
OSA is between 2 and 6 years of age,9 while other studies cite a high prevalence around 2-8 
years with a subsequent decline in frequency.70 Our original age parameters are based on the 
theory that children younger than 3 may have underdeveloped airways and patients older than 13 
are nearing their full growth potential and may start to develop adult risk factors for OSA such as 
obesity and high blood pressure. After analysis of the data, a reconsideration of age cutoffs is 
proposed, as it appears in this study that children younger than 4 and older than 16 are at most 
risk for OSA, yielding specificity as high as 88% and sensitivity as high as 61% (Figure 4). Thus 
these changes are taken into account in our revised scale. 
 The N in the modified STOPBANG screening tool represents neuromuscular disorders. 
Neuromuscular disorders related to abnormalities of muscle tone, hypotonia, and spasticity 
influence a child to have OSA.9 The results of this study show a weakly positive relationship to 
AHI (P=0.1482). This study was limited in that there was a very low sample size of patients who 
had a neuromuscular disorder- only 21 patients out of 153. This low sample size may have 
prevented a predictive value with AHI. Some of the neuromuscular disorders of subjects in this 
study were muscular dystrophy and cerebral palsy. Neuromuscular deficits, along with 
craniofacial abnormalities and soft tissue hypertrophy, are frequently the origin of airway 
narrowing.69 Patency of the upper airway is a reflection of the muscle activities. In 
neuromuscular disorders the decrease in muscle tone can greatly alter the airway. In disorders 
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such as duchenne muscular dystrophy and cerebral palsy, the presence of sleep disordered 
breathing arises because the weakened dilator and respiratory muscles are further weakened 
during sleep.61 Although neuromuscular disorders did not show a strong correlation to AHI in 
this study, it remains in the revised scale as it is cited as one of the main causes of OSA.32,35 
 The G in the modified STOPBANG represents genetic disorders and congenital disorders 
and like neuromuscular disorders, did not show a strong correlation to AHI in the current study 
(P=0.0648). Many of these disorders are the underlying etiology of upper airway obstruction as a 
result of craniofacial malformation.71,72 A wide range of these disorders results in variable 
expression in each patient with individualized respiratory compromise. Most often congenital 
disorders may result in the mandible failing to grow in utero.71,72 Children with Down syndrome 
fall into the genetic disorder category and it has been shown that 31 to 45% of Down syndrome 
children are affected by OSA because of characteristics such as midfacial hypoplasia, 
micrognathia, and muscular hypotonia that reduce the size of the upper airway.61,73 Other 
syndromes with craniofacial abnormalities such as Apert’s and Crouzon’s have been shown to be 
disposed to OSA.61,74 In the systematic review and meta-analysis by Canto 
micrognathia/retrognathia had a sensitivity=0% with a specificity=95%. Furthermore, midface 
hypoplasia overall had a sensitivity = 16% and a specificity = 100%.31 These results ascertain 
that craniofacial anomalies are not highly predictive of pediatric OSA. Like neuromuscular 
disorder patients, in our study there was a very small sample size from the data collected- only 
21 out of 153 subjects had a genetic/congenital disorder. We propose to keep genetic/congenital 
disorders in the screening tool as craniofacial anomalies and syndromes were ascertained to be a 
cause of OSA.32 
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 If the 7 revised components mentioned above were used to score the likelihood of OSA, a 
multiple logistic regression indicates that more components would have been statistically 
significant (see Table 10). Even though the p-values in the table are not entirely fair, as they are 
the result of post-hoc data mining, it does suggest that the additional factors of BMI risk, age 
risk, and instances of neuromuscular disorders or genetic/congenital disorders may be important 
indicators of higher OSA risk. Unfortunately, as snoring was measured in this study, this analysis 
did not give any statistical support for its continued inclusion. 
 There were several limitations in this retrospective chart review. The collection of data 
from the sleep questionnaire proved challenging because several questions pertained to the 
presence of a single variable and answers were varied. For instance, patients and parents had to 
answer several questions detailing the patient’s tiredness throughout the day. Often times some 
of the questions would be answered denying the symptom and several more ascertaining the 
presence of the symptom. The majority was recorded, but since several questions represented 
one variable this could have skewed the results. Much of the information collected was limited to 
the parents. Many of the completed sleep questionnaires had inconsistent answers recorded. For 
instance, the patient would have a very low ESS value but parents would indicate that the patient 
did indeed have excessive sleepiness during the daytime in the actual questionnaire. There 
remained a lack of verification from the parents reporting and it was not clear whether the patient 
or parent had filled out the questionnaire. Expectation bias most certainly may have existed in 
this study as the Examiner was recording the PSG results and also the presence of specific 
variables that suggest OSA. In an attempt to avoid expectation bias, when able, variables were 
recorded first on the data sheet prior to accessing the PSG results. Since data was collected 
routinely prior to this study, often variables were not recorded and information was missing, this 
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restricted the amount of subjects able to be used. Prior to 2011, all sleep questionnaires and 
patient information was recorded in paper charts. These charts were unable to be accessed at the 
time of data collection; as a result the sample size was less than originally projected. The sample 
size does not represent an average population of children as all patients were believed to have a 
sleep disorder problem and as a result were seeking a diagnosis; thus this study may contain 
selection bias. It is possible that patients were unable to replicate their natural sleep during the 
polysomnography and did indeed have OSA. Patients whose ages ranged from 0–18 were 
included in the data collection. Patients over a certain age (12–14) often are almost fully grown 
and considered adults, consequently variables in the older age range could have skewed 
characteristics specific for children. Lastly, because this study was retrospective, researchers 
were limited in what variables could be used in the screening tool as to what information had 
been previously collected. For instance, tonsillar hypertrophy was considered as an important 
screening tool but had not always been recorded by the clinician.  
 There were several variables that this study did not focus on but may be relevant to 
pediatric OSA. It has been frequently mentioned that there is a genetic component to children 
with OSA. Future studies may want to include evaluation of whether the parents or siblings 
currently have a sleep disorder. The siblings of children who have been treated for sleep 
disorders are more likely have sleep disordered breathing.11,75 In addition, children with a family 
history of OSA are four times more likely to have OSA compared to children from families with 
no OSA diagnosis.76,77 It is also recommended to define snoring both quantitatively and 
qualitatively to omit those children whose snoring is infrequent and not really suggestive of 
OSA. Mouth breathing during the daytime (sensitivity = 26%, specificity = 79%) and during 
sleep (sensitivity = 68%, specificity = 42%) was evaluated for diagnostic quality in a previous 
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study31. Despite the mediocre results, mouth breathing is easily diagnosed by dentists and may be 
a variable useful for screening patients. Ethnicity may also play a role in screening at risk 
pediatric patients for OSA. Literature cites that being African American is a risk factor,14,78-80  
however this was not found in our study. Kheirandish-Gozal et al. found that the prevalence of 
OSA was increased in poorly controlled asthmatic children;70 perhaps this variable should be 
included in future studies. Worthy of attention would be a prospective study in which variables 
typical of Pediatric OSA and commonly diagnosed clinically by dentists could be evaluated to 
determine a predictive value. Further evaluation is recommended to continue to strive and find a 
highly predictive screening tool for pediatric OSA. 
 Polysomnography studies have proven labor intensive and have shown to be inaccessive 
to children. Moreover Gozal ascertains that “development of simple, cheap, and reliable 
diagnostic tools that permit more expanded screening of at-risk populations, and enable accurate 
identification of the children with definitive disease or with definitive absence of disease would 
revolutionize the field and provide timely access to clinical care to a large sector of the pediatric 
population, thereby reducing the health burden of OSA”.30 This study attempted to further clarify 
which variables were strongly associated with childhood OSA, and thus could be used to develop 
a screening tool that would accurately predict the disorder in at risk children.  
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Conclusions 
 
 
The purpose of the study was to develop a concise and easy-to-use questionnaire as a screening 
tool to aid in the diagnosis of OSA in pediatric patients. The screening scale proposed 
(S(T1)OPBANG) proved to be predictive of pediatric OSA. Based on the results of this study 
and the review of the literature the following components are recommended to remain in a 
revised screening tool: presence of snoring, sleep obstruction, and tonsillar hypertrophy; BMI, 
age, neuromuscular disorders and genetic/congenital disorders. Worthy of attention would be to 
explore ethnicity factors, presence of asthma, and family history of OSA in future studies.   
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Table 1. Demographic Characteristics of Study Subjects (N=153)  
Characteristic N Percent       
Gender 
Female 70 45.8
Male 83 54.2
Race/ethnicity 
Asian 4 2.6
Black or African American 66 43.1
Hispanic 5 3.3
White 69 45.1
Unknown / Not Reported 9 5.9
Mean SD Median Range 
Age (years) 10.59 4.10 10.50 3.17 17.50
Age (months) 127.06 49.21 126.00 38.00 210.00
Height (M) 1.40 0.24 1.42 0.91 1.88
Weight (kg) 49.56 31.13 42.18 12.70 188.70
BMI (kg/mm2) (n=152) 23.32 8.85 21.17 11.26 59.69
BMI percentile 72.73 33.52 91.42 0.00 100.00
Epworth scale (n=112) 8.57 6.29 8.00 0.00 24.00
Abbreviation: SD = standard deviation,  
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Table 2. Risk Factors  
Risk Factor 
Risk 
factor N Percent 
Snore No 51 33.3 
Yes 91 59.5 
Unknown 11 7.2 
Tonsillar hypertrophy No 50 32.7 
Yes 31 20.3 
Unknown 72 47.1 
Epworth > 10 No 69 45.1 
Yes 43 28.1 
Unknown 41 26.8 
Obstruction No 80 52.3 
Yes 59 38.6 
Unknown 14 9.2 
Daytime neurobehavioral symptoms No 125 81.7 
Yes 26 17.0 
Unknown 2 1.3 
Excessive tiredness/irritability during 
daytime No 57 37.3 
Yes 79 51.6 
Unknown 17 11.1 
Neuro/Muscular disorder No 0 0.0 
Yes 21 13.7 
Unknown 132 86.3 
Genetic/Congenital disorder No 0 0.0 
Yes 21 13.7 
Unknown 132 86.3 
BMI percent >= 95 No 92 60.1 
Yes 60 39.2 
Unknown 1 0.7 
Age < 3 or > 13 No 105 68.6 
Yes 48 31.4 
  Unknown 0 0.0 
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Table 3. Apnea-Hypopnea Index  
Apnea-Hypopnea 
index  N Percent
0-none 96 62.75
1-mild 29 18.95
2-moderate 16 10.46
3-severe 12 7.84
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Table 4. Scales 
S(T1)OPBANG S(T2)OPBANG 
Score N Percent   N Percent
0 2 1.3 4 2.6
1 28 18.3 24 15.7
2 39 25.5 38 24.8
3 40 26.1 40 26.1
4 25 16.3 25 16.3
5 17 11.1 17 11.1
6 2 1.3   5 3.3
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Table 5. S(T1)OPBANG Scale Results  
S(T1)OPBANG Specificity Sensitivity
True 
Pos
True 
Neg
False 
Pos 
False 
Neg 
. 100% 0% 0 125 0 28 
6 99% 4% 1 124 1 27 
5 94% 39% 11 117 8 17 
4 78% 57% 16 97 28 12 
3 48% 68% 19 60 65 9 
2 21% 86% 24 26 99 4 
1 2% 100% 28 2 123 0 
0 0% 100% 28 0 125 0 
0 0% 100% 28 0 125 0 
Logistic regression P = 0.0007, AUC = 67.7% 
  
 45 
Table 6. S(T2)OPBANG Scale Results  
S(T2)OPBANG Specificity Sensitivity
True 
Pos
True 
Neg
False 
Pos 
False 
Neg 
. 100% 0% 0 125 0 28 
6 99% 14% 4 124 1 24 
5 90% 36% 10 113 12 18 
4 74% 50% 14 92 33 14 
3 46% 68% 19 57 68 9 
2 19% 86% 24 24 101 4 
1 3% 100% 28 4 121 0 
0 0% 100% 28 0 125 0 
0 0% 100% 28 0 125 0 
Logistic regression P = 0.0040, AUC = 64.3% 
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Table 7. Unadjusted Analysis Results 
OSA 
Risk indicator   Negative Positive  RR p-value
Snore No 55 7 11% 2.04 0.0642
Yes 70 21 23%
Tonsillar hypertrophy No 102 20 16% 1.57 0.2262
Yes 23 8 26%
Epworth > 10 No 90 20 18% 1.02 0.9515
Yes 35 8 19%
Sleep obstruction No 86 8 9% 3.98 0.0001
Yes 39 20 34%
neuroPsych or tired No 48 13 21% 0.77 0.4329
Yes 77 15 16%
BMI percent > 95 No 80 13 14% 1.79 0.0852
Yes 45 15 25%
Age < 3 or Age > 13 No 88 17 16% 1.42 0.3181
Yes 37 11 23%
Neuro/Muscular No 108 24 18% 1.05 0.9241
Yes 17 4 19%
Genetic/Congenital No 109 23 17% 1.37 0.4821
  Yes 16 5 24%    
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Table 8. Components of S(T1)OPBANG 
Component 
Chi-
square P-value  OR 95% CI 
S Snore=yes 0.17 0.6767 0.74 0.19 2.99
T Tonsillar hypertrophy=yes 1.35 0.2449 1.96 0.63 6.05
O Obstruction=yes 10.77 0.0010 * 7.56 2.26 25.27
P 
Neurobehavioral=yes or 
Tiredness=yes 0.99 0.3191 0.61 0.24 1.60
B BMI% > 95 1.30 0.2551 1.90 0.63 5.73
A Age < 3 or Age > 13 2.70 0.1004 2.42 0.84 6.96
N Neuromuscular=yes 2.09 0.1482 3.06 0.67 13.92
G Genetic/congenital=yes 3.41 0.0648 3.71 0.92 14.90
  All 8 components 23.84 0.0024 *       
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Table 9. Components of S(T2)OPBANG 
Component 
Chi-
square P-value  OR 95% CI 
S Snore=yes 0.04 0.8441 0.87 0.23 3.34
T Epworth 0.49 0.4831 1.52 0.47 4.86
O Obstruction=yes 10.73 0.0011 * 7.26 2.22 23.76
P 
Neurobehavioral=yes or 
Tiredness=yes 1.41 0.2344 0.52 0.18 1.53
B BMI% > 95 1.19 0.2752 1.83 0.62 5.44
A Age < 3 or Age > 13 2.20 0.1377 2.17 0.78 6.05
N Neuromuscular=yes 1.81 0.1787 2.77 0.63 12.19
G Genetic/congenital=yes 3.27 0.0704 3.68 0.90 15.09
  All 8 components 22.99 0.0034 *       
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Table 10. Proposed Components 
OSA Adjusted 
  Risk indicator   Negative Positive RR OR (95% CI) p-value   
S Snore No 55 7 11% 2.04 0.93 (0.21, 3.82) 0.9249
Yes 70 21 23%
T Tonsillar hypertrophy No 102 20 16% 1.57 2.11 (0.66, 6.72) 0.2057
Yes 23 8 26%
O Sleep obstruction No 86 8 9% 3.98 7.84 (2.41, 31.41) 0.0004 *
Yes 39 20 34%
B BMI percent>85 or <10 No 45 4 8% 2.85 4.02 (1.28, 15.93) 0.0155 *
Yes 79 24 23%
A Age younger than 4, older than 16 No 111 22 17% 1.81 4.33 (1.06, 18.34) 0.0410 *
Yes 14 6 30%
N Neuro/Muscular disorder No 108 24 18% 1.05 3.79 (0.76, 18.29) 0.1007
Yes 17 4 19%
G Genetic/Congenital disorder No 109 23 17% 1.37 5.03 (1.19, 21.22) 0.0289 *
    Yes 16 5 24%           
 
 50 
 
 
Figure 1. Results for S(T1)OPBANG 
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Figure 2. Receiver Operating Characteristic Curve for S(T1)OPBANG 
 
  
 52 
 
 
Figure 3. Receiver Operating Characteristic Curve for S(T2)OPBANG 
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Figure 4. BMI Percentile for Age versus Age 
Legend: AHI none ○, mild ● moderate ● and 12=severe ● 
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         Appendix 1 
Data Sheet 
 
Obstructive Sleep Apnea in Children                           Study #______ 
Demographics 
1. Date of PSG _______________________ 
2. Age at time of PSG (__y__m) ________________ 
(<4 or >12 yrs= 1, otherwise 0) 
3. Race (Choose one): Caucasian, African american, Asian, Hispanic other:_________________ 
4. Gender (M or F) ____________ 
Sleep Center Information  
5. Snore (No, Yes, unknown) _______________ 
6. Tonsillar hypertrophy (No, Yes, unknown) ________________ 
7. Obstruction (No, Yes, unknown) _______________  
8. Daytime neurobehavioral symptoms (No, Yes, unknown)_________________ 
a. ICD 314.01 Attention deficit disorder with Hyperactivity 
b. ICD 314.00 Attention deficit disorder without mention of Hyperactivity 
c. ODD oppositional defiant disorder 
d. _________________________________ 
9. Excessive tiredness/irritability during daytime (No, Yes, unknown) ______________ 
 
10. Weight __lb/kg and Height: ____inches/cm 
BMI if provided in chart:   ________________ 
BMI calculated by recorders:______________  
 
11. Neuro/Muscular disorder(fill in):________________________________ 
12. Genetic/Congenital disorder (fill in):_____________________________ 
13. Epworth scale __________________________________ 
 
14. AHI score_______________________
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Appendix 2 
 
VCU Center for Sleep Medicine Questionnaire 
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Appendix 3 
 
Epworth Scale 
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